Skip to main content

Table 2 Statistical analysis of genotyping of PRKCE SNP with respect to gender

From: Elucidating the role of missense SNP of protein kinase C epsilon in HCV-induced hepatocellular carcinoma

Patient and Control Data with respect to Gender

Genotype

Frequency Distribution %

Odds Ratio

Relative Risk

P value

Patients

Control

Value

95% CI

Value

95% CI

AA (F)

20.00%

30.19%

0.5781

0.2237–1.472

0.7404

0.4168–1.188

0.2635

GG (F)

64.00%

38.89%

2.794

1.262–6.054

1.711

1.130–2.675

0.0118

AG (F)

16.00%

31.48%

0.4146

0.1607–1.106

0.6019

0.3144–1.028

0.0716

AA (M)

12.24%

34.78%

0.2616

0.09103–0.7278

0.4630

0.2186–0.8535

0.0141

GG (M)

80.00%

36.96%

6.824

2.766–15.84

2.737

1.642–4.919

< 0.0001

AG (M)

8.00%

28.26%

0.2207

0.07444–0.6796

0.4041

0.1615–0.8405

0.0146